KALA BIO, Inc. - Common Stock, $0.001 par value per share (KALA)

Historical Holders from Q3 2022 to Q4 2025

Type / Class
Equity / Common Stock, $0.001 par value per share
Symbol
KALA on Nasdaq
Shares outstanding
9,818,182
Price per share
$0.58
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares
1,734,395
Total reported value
$2,653,735
% of total 13F portfolios
0%
Share change
-1,906,297
Value change
-$8,492,399
Number of holders
21
Price from insider filings
$0.58
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of KALA BIO, Inc. - Common Stock, $0.001 par value per share (KALA) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
OXFORD FINANCE LLC 16% $1,215,000 1,620,000 OXFORD FINANCE LLC 25 Nov 2025
BAKER BROS. ADVISORS LP 10% 0% $11,372,470 744,759 0% Baker Bros. Advisors LP 02 Oct 2025
SR ONE CAPITAL MANAGEMENT, LLC 4.6% -15% $5,255,568 -$1,020,402 344,176 -16% SR One Capital Management, LLC 14 Oct 2025
ADAR1 Capital Management, LLC 4.9% $1,270,559 298,955 ADAR1 Capital Management, LLC 31 Dec 2024
Point72 Asset Management, L.P. 0% -96% $393 -$717,340 257 -100% Point72 Asset Management, L.P. 30 Sep 2025
As of 30 Sep 2025, KALA BIO, Inc. - Common Stock, $0.001 par value per share (KALA) has 21 institutional shareholders filing 13F forms. They hold 1,734,395 shares. of 9,818,182 outstanding shares (18%) .

Top 25 institutional shareholders own 18% of the company.

Filer Ownership Nb Shares Share Change % Portfolio % Holdings Value
BAKER BROS. ADVISORS LP 10% 985,093 -18% 0.01% $1,507,192
Woodline Partners LP 2.5% 247,466 -18% 0% $378,623
VANGUARD GROUP INC 2.1% 210,826 +24% 0% $322,563
ADAR1 Capital Management, LLC 1.4% 141,995 -5.2% 0.02% $217,252
GEODE CAPITAL MANAGEMENT, LLC 0.69% 67,912 +20% 0% $103,949
STATE STREET CORP 0.29% 28,576 0% $43,721
BlackRock, Inc. 0.22% 21,407 +0.24% 0% $32,753
NORTHERN TRUST CORP 0.12% 11,524 +11% 0% $17,632
UBS Group AG 0.08% 8,193 +23997% 0% $12,536
Tower Research Capital LLC (TRC) 0.05% 5,076 +344% 0% $7,766
MORGAN STANLEY 0.02% 1,533 +58% 0% $2,347
BANK OF AMERICA CORP /DE/ 0.02% 1,523 +1454% 0% $2,330
Covestor Ltd 0.01% 1,264 +11% 0% $2,000
Caitong International Asset Management Co., Ltd 0.01% 736 0% $1,126
CITIGROUP INC 0.01% 721 0% $1,103
MAI Capital Management 0% 300 0% 0% $459
Steward Partners Investment Advisory, LLC 0% 120 0% 0% $184
JPMORGAN CHASE & CO 0% 51 -78% 0% $78
PNC Financial Services Group, Inc. 0% 46 0% $70
Legacy Wealth Managment, LLC/ID 0% 25 0% 0% $39
SBI Securities Co., Ltd. 0% 8 0% 0% $12
PERCEPTIVE ADVISORS LLC 0% 0 -100% $0
SR One Capital Management, LP 0% 0 -100% $0
Cormorant Asset Management, LP 0% 0 -100% $0
OSAIC HOLDINGS, INC. 0% 0 -100% $0

Institutional Holders of KALA BIO, Inc. - Common Stock, $0.001 par value per share (KALA) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price Investors
2025 Q4 10,359 $6,000 +$6,000 $0.58 1
2025 Q3 1,734,395 $2,653,735 -$8,492,399 $1.53 21
2025 Q2 3,640,815 $17,329,892 -$2,659,836 $4.76 28
2025 Q1 4,140,775 $23,727,155 +$3,688,829 $5.73 26
2024 Q4 3,460,017 $24,012,460 +$9,345,854 $6.94 29
2024 Q3 2,117,088 $12,067,800 +$82,464 $5.70 26
2024 Q2 2,091,840 $14,831,107 +$10,436,290 $7.09 27
2024 Q1 616,773 $4,884,504 +$713,767 $7.97 27
2023 Q4 525,810 $3,681,120 +$62,131 $7.00 23
2023 Q3 513,683 $4,572,074 +$1,116,796 $8.90 24
2023 Q2 380,984 $5,558,799 +$892,555 $14.59 26
2023 Q1 319,440 $4,808,013 -$2,074,855 $15.05 22
2022 Q4 324,124 $12,362,867 +$12,342,867 $38.15 27
2022 Q3 90,500 $20,000 +$20,000 $0.22 1